5Q4-22236-32112
4 vaccinations
10 coded responses
34 check-ins
10 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 327 / FL
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2021-01-04
Registered in v-safe
-
2021-01-04
Survey response — day 14, dose 1MedDRA: Cough, Fatigue, Headache, Pain, Pyrexia, SARS-CoV-2 test positive, Throat clearing — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Dec 23, 2020, feverish with body aches and headache. 24th additional mild fatigue. I later developed a very mild cough and throat clearing. On Dec 29 I tested for COVID and received positive results on Dec 30. No known exposure.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-04
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Good · Site: Pain · HeadacheFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Musculoskeletal stiffness, Rhinorrhoea — Feeling: Good · Muscle or body achesFree text: Runny nose periodically, and Stiff neck but likely not related.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Good · Fatigue or tirednessFree text: Runny nose stillMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Good · Fatigue or tirednessFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
- 2021-01-15
-
2021-01-24
Survey response — day 14, dose 2MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Cough, congestion. Runny nose.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-02-03
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-08-31
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-05
-
2021-10-12
Survey response — day 42, dose 3MedDRA: Chills — Feeling: GoodFree text: Occasional chills in body. No other symptoms.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-30
-
2022-03-01
Survey response — 6 months, dose 3MedDRA: Gastrointestinal disorder, Secretion discharge — Feeling: GoodFree text: Abdominal issues MucusMedDRA releases: 2024-11 · check-in free text available
-
2022-06-11
Dose 4 — Pfizer-BioNTech
- 2022-06-11
- 2022-06-12
-
2022-06-14
Survey response — days 1–6 daily, dose 4MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-06-15
- 2022-06-16
- 2022-06-17
- 2022-06-18
- 2022-06-25
- 2022-07-02
- 2022-07-09
- 2022-07-23
- 2022-09-10
-
2022-12-10
Survey response — 6 months, dose 4MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Head Cold. Head congestion. Runny nose. Cough.MedDRA releases: 2024-11 · check-in free text available
- 2023-06-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-08-31 | Pfizer-BioNTech | No |
| 4 | 2022-06-11 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 1 — day 14, dose 1
Symptoms: Dec 23, 2020, feverish with body aches and headache. 24th additional mild fatigue. I later developed a very mild cough and throat clearing. On Dec 29 I tested for COVID and received positive results on Dec 30. No known exposure.
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose
Systemic reaction (other): Runny nose periodically, and Stiff neck but likely not related.
Systemic reaction (other): Runny nose still
Systemic reaction (other): Runny nose
Release 2 — day 14, dose 2
Symptoms: Cough, congestion. Runny nose.
Release 10 — day 42, dose 3
Symptoms: Occasional chills in body. No other symptoms.
Release 11 — 6 months, dose 3
Symptoms: Abdominal issues Mucus
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Runny nose
Release 12 — 6 months, dose 4
Symptoms: Head Cold. Head congestion. Runny nose. Cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Throat clearing | ✓ | ✓ | ✓ |
| SRO | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release